A preliminary study looking at the impact of COVID-19 on cannabis patients, led by the University of Miami, will be utilising epidemiology expertise, and looking at data collected on the patterns and trends of medical cannabis patients during the coronavirus outbreak.
Currently, medical cannabis patients are facing delays in the procurement of medicines due to the crisis, making them a vulnerable group that may be impacted by the virus.